Articles tagged with “oncology-clinical-trials”

ASCO 2026: Ivonescimab HARMONi-6 Trial Results for NSCLC

Examine ASCO 2026 HARMONi-6 trial data for ivonescimab in 1L squamous NSCLC. Understand OS outcomes, PD-1xVEGF efficacy, and Summit Therapeutics US strategy.

45 min read

5/15/2026

ivonescimab harmoni-6 trial asco 2026 squamous nsclc pd-1xvegf bispecific summit therapeutics oncology clinical trials lung cancer therapy akeso biopharma overall survival

Daraxonrasib RAS(ON) Inhibitor: Pancreatic Cancer Results

Analyze the Phase 3 RASolute-302 trial results for daraxonrasib, a novel RAS(ON) inhibitor demonstrating significant survival benefit in pancreatic cancer.

40 min read

4/28/2026

daraxonrasib rmc-6236 pancreatic cancer ras(on) inhibitors kras mutations rasolute-302 targeted therapy oncology clinical trials